CSRP3-AS1

Across TCGA pan-cancer cohorts, CSRP3-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated CSRP3-AS1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher CSRP3-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CSRP3-AS1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and TGCT show a favorable association.

UVM, KIRC, and MESO are the cancer types where CSRP3-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.261	0.783	<.001	126	view →
KIRC	OS	Quartile	All	0.501	0.677	<.001	99	view →
MESO	OS	Quartile	III,IV	0.305	0.508	.008	67	view →
KIRP	DFS	Tertile	All	0.844	0.937	.001	64	view →
HNSC	OS	Quartile	II,III,IV	0.731	0.588	.006	59	view →
LIHC	OS	Tertile	III,IV	0.323	0.704	<.001	51	view →
LGG	OS	Tertile	All	0.720	0.839	<.001	29	view →
ACC	OS	Tertile	All	0.302	0.746	.004	23	view →
TGCT	DFS	Tertile	All	0.920	0.700	.003	16	view →
LUAD	DFS	Quartile	III,IV	0.408	0.706	.022	9	view →
BLCA	OS	Tertile	II,III,IV	0.695	0.563	.034	8	view →
LUSC	OS	Quartile	All	0.349	0.515	.015	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

CSRP3-AS1–UVM (DFS)

Open the UVM breakdown →